Bain and Cinven cement Stada
Bain Capital and Cinven will hold 93.61% of Stada’s share capital and voting rights after completing their public delisting tender offer for remaining shares in the German company, according to the two firms’ Nidda Healthcare holding company.
You may also be interested in...
Nidda Healthcare, the investment vehicle controlled by Bain Capital and Cinven, has decided on a share price for the final squeeze-out of Stada’s remaining minority shareholders.
As one of the largest players in the industry, Sandoz has undertaken several key measures to aid in the fight against the novel coronavirus outbreak, including maintaining stable prices for key measures and donating millions of doses of potential treatment options like hydroxychloroquine. CEO Richard Saynor sets out his thoughts on the ongoing pandemic and the role of the generics industry.
Stada’s owner has revealed plans to squeeze out the German firm’s remaining minority shareholders.